Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...

There seems to be a strong exposure-response relationship between nerandomilast and the preservation of FVC in patients with PPF and IPF.

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...

BOSTON, March 25, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm ...

After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.

Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.

Preclinical data indicate that inhaled treprostinil may be useful for the treatment of idiopathic pulmonary fibrosis (IPF) through an antifibrotic mechanism, a premise that is supported by clinical ...

Idiopathic pulmonary fibrosis, a rare progressive disease characterized by fibrosis in the alveoli of the lungs, has a median survival of 3 to 5 years if left untreated. Inhaled treprostinil slowed ...

CHICAGO, March 5, 2026 /PRNewswire/ -- The Pulmonary Fibrosis Foundation's Care Center Network has grown to include 96 sites in 40 states as part of its first expansion since 2023, marking a milestone ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Predicted survival has gone up from 46 years in 2015 to ...